Records View

Clinical Efficacy and Safety of muscle strengthening and balancing rehabilitation exercise for elders

Status Approved

  • First Submitted Date

    2017/09/07

  • Registered Date

    2017/11/17

  • Last Updated Date

    2017/10/27

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0002544
    Unique Protocol ID CUH-2017-02-031
    Public/Brief Title Rehabilitation exercise of muscle strength and balance for elders
    Scientific Title Clinical Efficacy and Safety of muscle strengthening and balancing rehabilitation exercise for elders
    Acronym
    MFDS Regulated Study No
    IND/IDE Protocol No
    Registered at Other Registry No
    Healthcare Benefit Approval Status
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number CUH-2017-02-031-001
    Approval Date 2017-04-27
    Institutional Review Board Name Chonbuk National University Hospital Institutional Review Board
    Institutional Review Board Address
    Institutional Review Board Telephone
    Data Monitoring Committee
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name Myoung-Hwan Ko
    Title Professor
    Telephone +82-63-250-1795
    Affiliation Jeonbuk National University Hospital
    Address Geonjiro 20, Deokjin-gu, Jeonju-si, Jeollabuk-do, 54907, Korea
    Contact Person for Public Queries
    Name Kap-Soo Han
    Title Research Professor
    Telephone +82-63-259-3462
    Affiliation Jeonbuk National University Hospital
    Address Geonjiro 20, Deokjin-gu, Jeonju-si, Jeollabuk-do, 54907, Korea
    Contact Person for Updating Information
    Name Kap-Soo Han
    Title Research Professor
    Telephone +82-63-259-3462
    Affiliation Jeonbuk National University Hospital
    Address Geonjiro 20, Deokjin-gu, Jeonju-si, Jeollabuk-do, 54907, Korea
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Multi-center Number of center : 2
    Overall Recruitment Status Recruiting
    Date of First Enrollment 2017-07-26 Actual
    Target Number of Participant 40
    Primary Completion Date 2018-07-25 , Anticipated
    Study Completion Date 2018-07-25 , Anticipated
    Recruitment Status by Participating Study Site 1
    Name of Study Jeonbuk National University Hospital
    Recruitment Status Recruiting
    Date of First Enrollment 2017-07-26 ,
    Recruitment Status by Participating Study Site 2
    Name of Study Pusan National University Hospital
    Recruitment Status Recruiting
    Date of First Enrollment 2017-09-11 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name Ministry of Health & Welfare
    Organization Type Government
    Project ID HI15C1529
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name Jeonbuk National University Hospital
    Organization Type Medical Institute
    2. Sponsor Organization
    Organization Name Pusan National University Hospital
    Organization Type Medical Institute
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    The aim of the study was to evaluate the clinical efficacy and safety of newly developed rehabilitaion exercise device based on the daily activities in stroke rehabilitation.Patients were randomized in two groups: one intervent group (20 patients) and a control group (20 patients). The first and second group received three times of balancing training of upper and lower extremity or conventional treatment per week, respectively and received totally 24 times of training.  
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
     Supportive Care
    Phase Not applicable
    Intervention Model Parallel  
    Blinding/Masking Open
    Allocation RCT
    Intervention Type Medical Device  
    Intervention Description
    Each group receives three times of rehabilitation training or conventional training per week, respectively and receives totally 24 times of training within 8 weeks
    Number of Arms 2
    Arm 1

    Arm Label

    Medical device exercise group

    Target Number of Participant

    20

    Arm Type

    Experimental

    Arm Description

    Three times of rehabilitation training using medical device per week, and totally 24 times of treatments within 8 weeks.  
    Arm 2

    Arm Label

    Conventional training group

    Target Number of Participant

    20

    Arm Type

    Active comparator

    Arm Description

    Three times of conventional rehabilitation training per week, and totally 24 times of treatments within 8 weeks.  
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s) * (R00-R99)Symptoms, signs and abnormal clinical and laboratory findings, NEC 
       (R54)Senility 
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    65Year~85Year

    Description

    1) Age of 65 to 85 years 
    2) Ability to understand and follow simple explanations and commands  
    
    Exclusion Criteria
    1) Medical conditions which may affect physical performance or the physical activity may become unsafe 
    2) Other severe conditions not able to participate in the treatments 
    3) Low cognitive or psychiatric conditions 
    4) Loss of Upper and lower extremities 
    5) Currently participating other clinical trial test
    Healthy Volunteers Yes
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome /Safety/Efficacy
    Primary Outcome(s) 1
    Outcome
    Five times sit to stand test
    Timepoint
    Pre-evaluation, Post-treatment(after completion of 18 treatment sessions), Post-treatment (at 4weeks) 
    Primary Outcome(s) 2
    Outcome
    KFES-I(Korean version of fall efficacy scale-international)
    Timepoint
    Pre-evaluation, Post-treatment(after completion of 18 treatment sessions), Post-treatment (at 4weeks) 
    Secondary Outcome(s) 1
    Outcome
    Berg balance test 
    Timepoint
    Pre-evaluation, Post-treatment(after completion of 18 treatment sessions), Post-treatment (at 4weeks) 
    Secondary Outcome(s) 2
    Outcome
    Timed Up and Go test
    Timepoint
    Pre-evaluation, Post-treatment(after completion of 18 treatment sessions), Post-treatment (at 4weeks) 
    Secondary Outcome(s) 3
    Outcome
    10m walking time
    Timepoint
    Pre-evaluation, Post-treatment(after completion of 18 treatment sessions), Post-treatment (at 4weeks) 
    Secondary Outcome(s) 4
    Outcome
    Chair sit and reach test
    Timepoint
    Pre-evaluation, Post-treatment(after completion of 18 treatment sessions), Post-treatment (at 4weeks) 
    Secondary Outcome(s) 5
    Outcome
    Lower extremity MMT (Manual muscle test)
    Timepoint
    Pre-evaluation, Post-treatment(after completion of 18 treatment sessions), Post-treatment (at 4weeks) 
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement Not provided at time of Registration
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동